Cite
HARVARD Citation
Molga, A. et al. (2020). Comprehensive geriatric assessment predicts azacitidine treatment duration and survival in older patients with myelodysplastic syndromes. Journal of geriatric oncology. 11 (1), pp. 114-120. [Online].